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Abstract
Background
Intermittent severe energy restriction is popular for weight management. To investigate
whether intermittent moderate energy restriction may improve this approach by enhancing
weight loss efficiency, we conducted a study in mice, where energy intake can be
controlled.
Methods
Male C57/Bl6 mice that had been rendered obese by an ad libitum diet high in fat and sugar
for 22 weeks were then fed one of two energy-restricted normal chow diets for a 12-week
weight loss phase. The continuous diet (CD) provided 82% of the energy intake of age-
matched ad libitum chow-fed controls. The intermittent diet (ID) provided cycles of 82% of
control intake for 5–6 consecutive days, and ad libitum intake for 1–3 days. Weight loss effi-
ciency during this phase was calculated as (total weight change) [(total energy intake of
mice on CD or ID)–(total average energy intake of controls)]. Subsets of mice then under-
went a 3-week weight regain phase involving ad libitum re-feeding.
Results
Mice on the ID showed transient hyperphagia relative to controls during each 1–3-day ad
libitum feeding period, and overall ate significantly more than CDmice (91.1±1.0 versus
82.2±0.5% of control intake respectively, n = 10, P<0.05). There were no significant differ-
ences between CD and ID groups at the end of the weight loss or weight regain phases with
respect to body weight, fat mass, circulating glucose or insulin concentrations, or the insulin
resistance index. Weight loss efficiency was significantly greater with ID than with CD
(0.042±0.007 versus 0.018±0.001 g/kJ, n = 10, P<0.01). Mice on the CD exhibited
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significantly greater hypothalamic mRNA expression of proopiomelanocortin (POMC) rela-
tive to ID and control mice, with no differences in neuropeptide Y or agouti-related peptide
mRNA expression between energy-restricted groups.
Conclusion
Intermittent moderate energy restriction may offer an advantage over continuous moderate
energy restriction, because it induces significantly greater weight loss relative to energy def-
icit in mice.
Introduction
Weight loss by lifestyle intervention is almost twice as effective as anti-diabetic drugs (metfor-
min) for preventing the progression to overt diabetes in people with overweight or obesity [1].
Weight loss therefore offers a simple and powerful strategy for preventing not only type 2 dia-
betes but also other diseases. However, adhering to the long-term energy restriction that is
required to achieve lasting, clinically significant weight loss is notoriously difficult. Improved
weight loss strategies are urgently needed.
Studies in humans and animals increasingly suggest that intermittent energy restriction is
on par with, or even superior to, continuous energy restriction with regards to various health
benefits. These include improved glucose homeostasis [2–9], improved cardiovascular and
cerebrovascular health [9–11], potentially reduced tumour initiation and growth [12,13], and
delayed age-related neurodegeneration and cognitive impairments [14]. Against this back-
ground, weight reducing diets involving intermittent energy restriction have recently gained
popularity amongst health professionals and members of the public alike [15,16]. Such eating
patterns involve restricting energy intake by varying degrees for a pre-defined period of time,
and eating ad libitum (i.e. to satisfy appetite)–or at least more than during the energy-restricted
period—at all other times. The most common form of intermittent energy restriction is ‘inter-
mittent fasting’, where energy intake is severely restricted to ~0–50% of energy requirements
for short periods (typically 1 to 7 consecutive or non-consecutive days per week) [17]. During
periods of greater energy intake, there may or may not be restrictions placed on the types and
amounts of foods and beverages consumed [17].
Recent reviews of clinical trials in individuals with overweight or obesity suggest that inter-
mittent severe energy restriction results in equivalent–albeit not superior—weight or fat loss
and improvements in cardiovascular disease risk factors and fasting circulating insulin levels
and insulin sensitivity (as assessed by homeostatic model assessment for insulin resistance,
HOMA-IR) relative to moderate continuous energy restriction [17–20]. As such, intermittent
severe energy restriction is increasingly recognised as a viable and equivalent option for weight
loss [17].
One potential limitation of intermittent severe energy restriction is that it may not produce
optimally efficient weight loss, because severe energy restriction as defined above has been
shown to result in less weight loss per unit of energy restriction than more moderate energy
restriction in adult humans with obesity [21–23]. We hypothesized that intermittentmoderate
energy restriction would improve the efficiency of weight loss relative to continuous moderate
energy restriction. We define moderate energy restriction as a diet providing ~70–80% of
energy requirements, as in human weight loss interventions that commonly restrict energy
intake by ~2,000 kJ/day. Our rationale was that while energy restriction—notably severe energy
Intermittent vs Continuous Dieting in Obese Mice
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restriction—is known to induce adaptive responses such as reduced energy expenditure that
inhibit further weight loss and promote weight regain [24,25], some of these effects were
reported to be normalized or attenuated by a period of ad libitum food intake or weight main-
tenance [26–31]. Thus, providing ‘metabolic rest periods’ via ad libitum feeding and increased
food intake would be hypothesized to attenuate the energy-conserving effects of energy restric-
tion, thereby improving weight loss efficiency (weight loss per unit energy restriction), poten-
tially providing a more effective angle for human obesity treatment. We tested this hypothesis
in mice, where manipulating energy intake and determining actual intake are relatively
straightforward, unlike in humans, where adherence to specific prescriptions of energy intake
and determining actual intake are challenging [32].
Materials and Methods
Ethics, animals, experimental design, calculation of weight loss
efficiency, tissue collection and body composition assessment
All research and animal care procedures were approved by the Garvan Institute/St Vincent’s
Hospital Animal Ethics Committee (approved protocol #04/27) and were in agreement with
the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.
45 male C57/Bl6 mice at 3 weeks of age were purchased from the Animal Resources Centre
(Canning Vale, Western Australia, Australia). Mice were housed under conditions of con-
trolled temperature (22°C) and illumination (12-hour light-dark cycle, lights on at 7:00 hours).
At 4 weeks of age, mice were housed in groups of 4–5 mice per cage and were allowed to feed
ad libitum for 22 weeks on one of two diets as shown in Fig 1; normal chow (8 mice) or a high
fat, high sugar (obesogenic) diet (37 mice). This period is referred to as the “weight gain
phase”. The normal chow provided 8% of energy from fat, 21% of energy from protein, 71% of
energy from carbohydrates, and 10.9 kJ/g (Gordon’s Specialty Stock Feeds, Yanderra, New
SouthWales, Australia). The high fat diet was normal chow supplemented with fat and sucrose.
It provided 46% of energy from fat, 21% of energy from protein, 33% of energy from carbohy-
drates and 19.7 kJ/g. The diet was based on the composition of rodent diet (Catalog number:
D12451; Research Diets, New Brunswick, NJ, USA), with the exception that safflower oil and
copha were used in place of soybean oil and lard. All data for food intake are presented in units
of energy intake (kJ/day) rather than weight consumed, due to the different energy densities of
normal chow and the high fat diet.
During the weight gain phase, body weight and energy intake were determined approxi-
mately once a week at a similar time of day. Energy intake (kJ/day) was calculated as [[(weight
of food placed in hopper)–(weight of food remaining in hopper)] x (energy density of food in
kJ/g)] [(number of mice per cage) x (number of days)]. Following the weight gain phase, 9
mice that had not gained significant amounts of body weight despite 22 weeks on the high fat
diet were excluded from the study (Fig 1). The body weight of these mice (n = 9; 29.2±0.6 g)
was not significantly different from that of the age-matched chow-fed mice (n = 8; 28.2±0.6 g).
This finding is in keeping with the observation that C57/Bl6 mice show variable responses to a
high fat diet, with some individual animals being resistant to diet-induced weight gain and
metabolic perturbations [33,34]. The remaining mice were divided into 4 experimental groups
for a 12-week (85-day) “weight loss phase” as shown in Fig 1. Two control groups, namely the
“continuous ad libitum chow” (CAC, n = 8) and “continuous ad libitum high fat diet” (CAF,
n = 8), had ad libitum access to normal chow or the high fat diet, respectively, for this and all
other phases of the experiment. The remaining obese, high fat fed mice were transferred from
group housing to individual housing and were randomly allocated to either the “continuous
diet” (n = 10) or the “intermittent diet” (n = 10). Mice in these two groups were allowed to
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recover normal food intake levels prior to commencing experimentally imposed energy restric-
tion. Mice on the continuous diet and intermittent diet received normal chow for the weight
loss phase. Mice on the continuous diet were given weighed portions of normal chow that were
equivalent to 82% of the ad libitum chow intake of age-matched mice in the CAC group, mim-
icking the moderate energy restriction that is frequently prescribed for the dietary management
of overweight and obesity in humans. Mice on the intermittent diet were alternated between 5-
to 6-day periods (average 5.6 days) of restricted chow intake, at a level equivalent to that of
mice in the continuous diet group, followed by 1- to 3- day periods (average 2.1 days), where
they were allowed to eat normal chow ad libitum. Actual energy intake was determined daily in
these individually housed mice as described above.
Weight loss efficiency from the start to the end of the weight loss phase was calculated as
(total weight change for each mouse on the continuous or intermittent diet) (total energy
deficit), where total energy deficit is (total energy intake of each mouse on the continuous or
intermittent diet)–(total average energy intake of CAC controls). It is expressed in units of g/kJ
(i.e. grams lost per kJ of energy restriction relative to the energy intake of age-matched control
Fig 1. Study flow chart.CAC, continuous ad libitum chow; CAF, continuous ad libitum high fat; CD, continuous diet; ID, intermittent diet.
doi:10.1371/journal.pone.0145157.g001
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mice during the 12-week weight loss phase). This calculation is based on a deficit-efficiency
factor of (body energy loss) (dietary energy deficit) that was previously developed to quantify
the effectiveness of weight-reduction interventions [23].
At the end of the weight loss phase, 4 mice from the CAC group, 5 mice from the CAF, and 5
mice from each of the continuous diet and intermittent diet groups were fasted from 8:00 hours
and then culled by cervical dislocation between 11:00 and 14:00 hours. Trunk blood was then
collected and serum was subsequently collected and frozen at -80°C until analysis as described
below. Brains were isolated and frozen hypothalamus side up, on an aluminium plate on dry ice.
They were then stored at -80°C until subsequent analysis as described below. The carcasses were
scanned (with the head excluded and the tail included) using dual energy X-ray absorptiometry
(Lunar PIXImus2 mouse densitometer; GE Healthcare, Waukesha, WI, USA) to determine lean
(g) and fat (% and g) mass. The following white adipose tissue (WAT) depots and other tissues
were then dissected and weighed; the inguinal (WATi), epididymal (WATe), retroperitoneal
(WATr) and mesenteric (WATm)WAT depots, the interscapular brown adipose tissue (BAT)
depot, as well as the pancreas, liver, heart, kidney, spleen, testes and the seminal vesicles.
All remaining mice then proceeded to a 3-week (22-day) “weight regain phase”, where mice
from the energy-restricted groups were given ad libitum access to normal chow for the first 10
days and to the high fat diet for the ensuing 12 days. Following the weight regain phase, mice
were culled and the carcasses and tissues were collected as described above.
Determination of fasting serum glucose, insulin and insulin resistance
Serum glucose and insulin concentrations were measured using a glucose oxidase kit from
Trace Scientific (Clayton, Victoria, Australia) and a radioimmunoassay kit from Millipore Cor-
poration (Billerica, MA, USA), respectively. From these, an index of insulin resistance was esti-
mated using the formula for the homeostatic model assessment for insulin resistance
(HOMA-IR), which is (fasting insulin [mU/L] x fasting glucose [mmol/L])/22.5 [35].
Real time PCR
To determine the hypothalamic mRNA expression levels of neuropeptide Y (NPY), agouti-
related peptide (AgRP) and proopiomelanocortin (POMC), the hypothalamic region of frozen
brains was dissected out and total RNA was isolated using Trizol Reagent (Sigma, St Louis,
MO, USA) following the manufacturer’s protocol. The quality and concentration of total RNA
was measured with a spectrophotometer (Nanodrop 1000, NanoDrop Technologies, LLC,
USA). 1 μg of total RNA was reverse transcribed into cDNA using the Superscript III First-
Strand Synthesis System (Invitrogen, Mount Waverley, Victoria, Australia). Quantitative real-
time PCR using primers for NPY, AgRP or POMC was carried out on a Light-Cycler1 480
Real-Time PCR system (Roche Applied Science, Germany) using SensiMix™ Probe (Bioline
Australia Pty Ltd, Alexandria, New South Wales, Australia) following the manufacturer’s
instructions. Expression of the ribosomal protein L19 (RPL19) was used to normalize mRNA
expression levels of genes of interest. Primers for NPY, AgRP and POMC were as listed below:
NPY: Forward: GAAAGCACAGAAAACGCCCCCAG, Reverse: AAATGGGGCGGAGTCCAGC
CTA; AgRP: Forward: TTTGTCCTCTGAAGCTGTATGC, Reverse: GCATGAGGTGCCTCCCTA;
POMC: Forward: AGTGCCAGGACCTCACCA, Reverse: CAGCGAGAGGTCGAGTTTG.
Statistical analysis
Data were analyzed using SPSS version 18 (SPSS Inc, Chicago, Illinois, USA). Repeated-mea-
sures analysis of variance (ANOVA) was used to evaluate energy intake, body weight and
WAT depot weights, with time or depot type as the within-subject factor, and group (CAC,
Intermittent vs Continuous Dieting in Obese Mice
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CAF, continuous diet and intermittent diet) as the between-subject factor. Area under the
curves (AUCs) for energy intake and body weight was calculated using the trapezoidal rule.
One-way ANOVA was used to analyze AUCs for energy intake and body weight, as well as
weight loss efficiency, body composition as determined by dual energy X-ray absorptiometry,
the weight of dissected tissues (besides WAT depots), serum glucose and insulin concentra-
tions, the insulin resistance index as well as hypothalamic NPY, AgRP and POMCmRNA
expression levels, with group as a factor. Post-hoc comparisons, adjusted for multiple compari-
sons by Bonferroni's correction, were performed where ANOVA revealed significant effects.
Statistical significance was accepted at P<0.05. Data are presented as means ± SEM.
Results
Energy intake was greater on the intermittent than on the continuous diet
The daily energy intake of all 4 groups of mice throughout the 3 phases of the experiment
(weight gain, weight loss and weight regain) are shown in Fig 2A, and the area under the curves
(AUCs) for each group during each phase are shown in Table 1. As expected, mice in the CAF
group consumed significantly more energy per day than mice in the CAC group throughout all
3 phases of the experiment. During the weight gain phase, mice in the continuous and intermit-
tent diet groups, which also had ad libitum access to the high fat diet at this time, consumed a
similarly elevated number of kJ per day relative to those in the CAF group.
At the start of the weight loss phase there was a spontaneous drop in energy intake in mice in
the continuous and intermittent diet groups, corresponding to their transfer from group hous-
ing to individual housing and their switch from the high fat diet to normal chow, but energy
intake recovered to values indistinguishable from that of mice in the CAC group within a week
(Fig 2A). For the remainder of the weight loss phase, the 24-hour energy intake of mice on the
continuous diet was experimentally restricted to an overall average of 82% of that of mice in the
CAC group, as shown in Fig 2A and Table 1. This level of energy intake was significantly less
than that of CAC mice (Table 1). Mice on the intermittent diet did not eat significantly less
overall than those in the CAC group during the weight loss phase (Table 1), despite the fact that
on most days their energy intake was also experimentally restricted to an overall average of 82%
of that of mice in the CAC group. This lack of overall difference in energy intake compared to
CAC controls despite periods of energy restriction is because when mice on the intermittent
diet were given ad libitum access to normal chow, they ate markedly more than mice in the
CAC or continuous diet groups, as shown in Fig 2A. The average energy intake of these mice on
the first and—when available—second and third day of ad libitum food intake was 139±9%, 105
±3%, and 101±6% that of control mice in the CAC group. The result of these intermittent
increases in energy intake is that mice on the intermittent diet consumed 11.5%more energy
(P<0.05) than mice on the continuous diet over the entire weight loss phase (Table 1).
During the weight regain phase, when mice in both the continuous diet and intermittent
diet groups were given ad libitum access to normal chow for the first 10 days and to the high
fat diet for the ensuing 12 days, both groups showed similar increases in energy intake, with no
significant difference between the two groups (Fig 2A, Table 1).
No difference in final body weight between mice on the continuous or
intermittent diet
There was no significant difference among the four groups of mice with respect to body weight
at the start of the experiment at 4 weeks of age (Fig 2B, Table 1). As seen in Fig 2B and Table 1,
mice in the CAF group had greater body weights than mice in the CAC group throughout all 3
Intermittent vs Continuous Dieting in Obese Mice
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Fig 2. Energy intake (A) and body weight (B) during the weight gain, loss and regain phases.CAC, continuous ad libitum chow; CAF, continuous ad
libitum high fat diet; CD, continuous diet; ID, intermittent diet. Data are means ± SEM of 3–10 mice per group as shown in Fig 1.
doi:10.1371/journal.pone.0145157.g002
Intermittent vs Continuous Dieting in Obese Mice
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phases of the experiment. During the weight gain phase, mice in the continuous diet and inter-
mittent diet groups, which also had ad libitum access to the high fat diet at this time, had a sim-
ilarly elevated body weight to those in the CAF group (Fig 2B, Table 1).
At the start of the weight loss phase there was a drop in body weight in mice in the continu-
ous diet and intermittent diet groups, corresponding to their transient spontaneous hypohagia
(Fig 2). Mice on the continuous diet had a lower body weight than those on the intermittent
diet during the first part of the weight loss phase, but by the end of the weight loss phase (i.e. at
the start of the weight regain phase) there was no significant difference between these two
groups with respect to body weight (Fig 2B, Table 1), and no difference overall as assessed by
ANOVA or AUC (Table 1). It is noteworthy that the body weight of both groups of energy-
restricted mice was significantly lower than that of mice in the CAC group by the end of the
weight loss phase (i.e. by the start of the weight regain phase) (Fig 2B, Table 1), indicating that
their weight was lower than their defended body weight (‘set point’).
During the weight regain phase, mice in the continuous diet and intermittent diet groups
showed similar body weights, with no significant difference between the two groups, and no signifi-
cant difference from the body weight of mice in the CAC group in this timeframe (Fig 2B, Table 1).
Table 1. Energy intake, body weight and weight loss efficiency during the weight gain, loss or regain phases of the experiment.
CAC CAF CD ID
AUC energy intake (kJ.day)
Weight gain phase 35.0±0.1 59.3±0.9* 57.5±0.9* 57.3±0.8*
Weight loss phase 42.2±1.1 68.1±1.9* 34.6±0.2*§ 38.6±0.6§#
Weight regain phase: total 44.2±2.7 70.5±0** 63.6±1.1* 66.3±1.1*
Weight regain phase: chow - - 53.3±1.0 55.4±1.3
Weight regain phase: fat - - 66.8±1.7 69.8±1.0
AUC Body weight (g.day)
Weight gain phase 23.2±0.5 26.0±0.4* 27.1±0.6* 26.6±0.6*
Weight loss phase 28.2±0.6 36.5±0.8*** 25.5±0.3**§§§ 27.4±0.4§§§
Weight regain phase: total 27.4±0.7 37.0±0.8*** 27.2±0.6§§§ 26.9±0.3§§§
Weight regain phase: chow - - 25.4±0.4 24.9±0.3
Weight regain phase: fat - - 25.7±0.5 25.7±0.2
Body weight (g)
Start of weight gain phase 15.3±0.8 16.5±0.6 15.7±0.5 16.2±0.5
Start of weight loss phase 28.2±0.6 33.9±0.8*** 35.0±0.8*** 35.1±0.8***
Start of weight regain phase 29.2±0.7 40.0±1*** 23.8±0.3***§§§ 25.3±0.3***§§§
End of weight regain phase 29.1±0.7 39±0.7* 30.1±0.9§ 31.1±0.5§
Weight loss efﬁciency (g/kJ)
Weight loss phase - - 0.018±0.001 0.042±0.007##
CAC, continuous ad libitum chow; CAF, continuous ad libitum high fat diet; CD, continuous diet; ID, intermittent diet; AUC, area under the curve. Data are
means ± SEM of the number of mice shown in Fig 1.
* P<0.05,
** P<0.01,
*** P<0.001 versus CAC.
§ P<0.05,
§§ P<0.01,
§§§ P<0.001 versus CAF.
# P<0.05,
## P<0.01 versus CD.
doi:10.1371/journal.pone.0145157.t001
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PLOS ONE | DOI:10.1371/journal.pone.0145157 January 19, 2016 8 / 20
Weight loss efficiency was significantly greater on the intermittent than
on the continuous diet
During the weight loss phase, there was a significant, 2.3-fold greater weight loss efficiency
(total weight loss total energy deficit) for mice on the intermittent diet compared to those on
the continuous diet (Table 1). This is because whereas both groups of energy-restricted mice
exhibited similar total weight loss (Fig 2B, Table 1), the total energy deficit of mice on the inter-
mittent diet during the 12-week weight loss phase (304.5±47.7 kJ) was less than half that of
mice on the continuous diet (646.9±16.8 kJ). This means that for every kJ of deficit in energy
intake relative to the energy intake of age-matched control mice, mice on the intermittent diet
lost 2.3 times as much weight as mice on the continuous diet.
No difference in body composition between mice on the continuous or
intermittent diet
In keeping with obesity induced by ad libitum access to the high fat diet, mice in the CAF
group exhibited significantly higher fat masses (both in absolute weight and as a percent of
body weight)–as determined by dual energy X-ray absorptiometry (Fig 3A and 3B) as well as
by adipose tissue depot dissection (Fig 4A–4D)—compared to mice in every other group. At
the end of the weight loss phase, fat masses in the previously high fat-fed mice from the contin-
uous and intermittent diet groups were significantly less than that of mice in the CAF group,
with no significant difference between these two groups or the CAC group (Fig 3A and 3B, Fig
4A and 4B). At the end of the weight regain phase, fat masses of mice in the continuous and
intermittent diet groups remained statistically indistinguishable from each other, albeit both
groups exhibited significantly greater total fat mass as determined by dual energy X-ray absorp-
tiometry (Fig 3A and 3B) but not necessarily by dissection of individual fat depots (Fig 4C and
4D) than mice in the CAC group at this time point.
As seen from data on lean mass measured at the end of the weight loss phase (Fig 3C),
weight loss produced significant reductions in lean mass in mice on the continuous and inter-
mittent diets relative to corresponding values from CAF and / or CAC groups, in keeping with
a known effect of weight loss to reduce fat free mass [36]. However, there was no significant dif-
ference in lean mass between mice on either of the two energy-restricted diets at this time point
(Fig 3C). At the end of the weight regain phase, there were no significant differences in lean
mass amongst any of the groups (Fig 3C).
The continuous but not the intermittent diet reduced the weight of male
reproductive organs
Following the weight loss phase, but not the weight regain phase, there was a significant reduc-
tion in relative weight (as a percent of body weight) of the seminal vesicles of mice on the con-
tinuous but not on the intermittent diet (Table 2). There were no significant differences in
testes weight among groups (Table 2). At the end of the weight loss and weight regain phases,
there were no differences amongst groups with respect to absolute (g) or relative (%) weight of
the pancreas, liver, heart, kidney or spleen (data not shown).
No difference in serum glucose, insulin or the insulin resistance index
between mice on the continuous or intermittent diet
In keeping with an euglycemic obesity syndrome, mice in the CAF group exhibited no signifi-
cant change in serum glucose and significantly greater serum insulin concentrations compared
to corresponding values in the CAC group at the end of both the weight loss and weight regain
Intermittent vs Continuous Dieting in Obese Mice
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Fig 3. Body composition as determined by dual energy X-ray absorptiometry. (A) Fat mass (g), (B) fat
mass (% of body weight) and (C) lean mass (g) at the end of the weight loss and weight regain phases. CAC,
continuous ad libitum chow; CAF, continuous ad libitum high fat diet; CD, continuous diet; ID, intermittent
diet. Data are means ± SEM of 3–10 mice per group as shown in Fig 1. * P<0.05, ** P<0.01, *** P<0.001
versus CAC. §§ P<0.01, §§§ P<0.001 versus CAF.
doi:10.1371/journal.pone.0145157.g003
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phases (Table 2). At the end of the weight loss phase, mice on the continuous and intermittent
diets had significantly lower serum glucose and insulin concentrations than those in the CAF
group, with no significant difference between the intermittent and continuous diet groups or
from the CAC group (Table 2). Both the continuous diet and intermittent diet groups exhibited
a lower insulin resistance index than that of the CAF group, significantly so for the continuous
diet group (Table 2). At the end of the weight regain phase, serum insulin concentrations and
the insulin resistance index were significantly greater in the continuous but not the intermittent
Fig 4. Body composition as determined by adipose tissue dissection.White adipose tissue (WAT) and brown adipose tissue (BAT) depot masses are
presented in absolute weights (g) and as a percent of body weight (%) at the end of the weight loss (A and B) and weight regain (C and D) phases. CAC,
continuous ad libitum chow; CAF, continuous ad libitum high fat diet; CD, continuous diet; ID, intermittent diet; WATi, inguinal WAT; WATe, epididymal WAT;
WATr, retroperitoneal WAT; WATm, mesenteric WAT; WATt, sum of the above 4WAT depot masses. Data are means ± SEM of 3–10 mice per group as
shown in Fig 1. * P<0.05, ** P<0.01, *** P<0.001 versus CAC. §§§ P<0.001 versus CAF.
doi:10.1371/journal.pone.0145157.g004
Intermittent vs Continuous Dieting in Obese Mice
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diet group relative to CAC mice, but values were not significantly different from mice in the
CAF group (Table 2). Again, there was no significant difference between the continuous diet
and the intermittent diet group (Table 2).
The continuous but not the intermittent diet increased hypothalamic
expression of proopiomelanocortin
To explore possible mechanisms for the significantly greater weight loss efficiency with inter-
mittent compared to continuous moderate energy restriction, we investigated hypothalamic
mRNA expression of key regulators of energy homeostasis. Genes under investigation were the
orexigenic peptides, neuropeptide Y (NPY) and agouti related peptide (AgRP), as well as proo-
piomelanocortin (POMC), which produces several peptides including the anorexigenic alpha
melanocyte stimulating hormone (α-MSH) and the orexigenic opioid peptide, β-endorphin
[37]. As shown in Fig 5A, whereas mice in the CAF group showed significant up-regulation of
hypothalamic NPY expression relative to mice in the CAC condition, in keeping with
Table 2. Weight (g and as a % of body weight) of seminal vesicles and testes, and serum glucose and insulin levels, as well as insulin resistance
index, at the end of the weight loss and weight regain phases of the experiment.
CAC CAF CD ID
End of weight loss phase
Seminal vesicles
Weight (g) 0.21±0.02 0.22±0.01* 0.11±0.01***§§ 0.16±0.01***§§#
Weight (%) 0.69±0.05 0.56±0.04 0.47±0.02** 0.64±0.04#
Testes
Weight (g) 0.110±0.004 0.102±0.006 0.082±0.015 0.100±0.003
Weight (%) 0.36±0.02 0.26±0.02 0.33±0.06 0.38±0.01
Glucose / insulin
Glucose (mM) 6.8 ± 0.8 8.2 ± 0.8 4.6 ± 0.3§§ 4.3 ± 0.3§§
Insulin (pM) 137 ± 18.7 235 ± 22.4* 59.3 ± 6.3§§§ 84.3 ± 23.2§§§
Insulin resistance index 19.9 ± 0.7 29.8 ± 3.7 12.8 ± 1.1§ 19.0 ± 4.8
End of weight regain phase
Seminal vesicles
Weight (g) 0.24±0.02 0.23±0.01 0.23±0.01 0.24±0.01
Weight (%) 0.80±0.05 0.57±0.02 0.74±0.05 0.74±0.02
Testes
Weight (g) 0.113±0.018 0.103±0.026 0.120±0.010 0.102±0.004
Weight (%) 0.38±0.06 0.26±0.06 0.38±0.03 0.32±0.01
Glucose / insulin
Glucose (mM) 7.0 ± 0.6 8.5 ± 0.4 8.3 ± 0.3 8.1 ± 1.0
Insulin (pM) 126 ± 10.4 239 ± 25.9* 248 ± 26.1** 209 ± 24
Insulin resistance index 18.0 ± 1.2 28.2 ± 2.5 30.2 ± 3.5* 26.0 ± 2.1
CAC, continuous ad libitum chow; CAF, continuous ad libitum high fat diet; CD, continuous diet; ID, intermittent diet. Data are means ± SEM of 3–10 mice
per group as shown in Fig 1.
* P<0.05,
** P<0.01,
*** P<0.001 versus CAC.
§§ P<0.01,
§§§ P<0.001 versus CAF.
# P<0.05 versus CD.
doi:10.1371/journal.pone.0145157.t002
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Fig 5. Hypothalamic expression of regulators of energy balance at the end of the weight loss phase.
Whole hypothalamic blocks were used for the determination of (A) neuropeptide Y (NPY), (B) agouti related
peptide (AgRP) and (C) proopiomelanocortin (POMC) mRNA expression levels by quantitative PCR. Values
are expressed as fold-change in expression relative to that of the housekeeping gene, ribosomal protein L19
and as a percentage of CACmice (open bars). CAC, continuous ad libitum chow; CAF, continuous ad libitum
Intermittent vs Continuous Dieting in Obese Mice
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previously observed effects of dietary obesity in rodents [38,39], and whereas hypothalamic
NPY expression was reduced relative to values in CAF mice in both groups of energy-restricted
mice, there was no significant difference in this parameter for mice on the continuous or inter-
mittent diet. There were no significant differences in hypothalamic AgRP mRNA expression
amongst mice in any of the four groups (Fig 5B). In contrast, mice on the continuous diet
showed a dramatic and significant increase in hypothalamic POMCmRNA expression levels
relative to control mice (CAC, CAF), and no such significant effect was seen in mice on the
intermittent diet (Fig 5C).
Discussion
This study shows that moderate energy restriction (18%), applied in intermittent bursts of 5–6
consecutive days per week and separated by 1–3 consecutive days of ad libitum energy intake,
resulted in more efficient weight loss than continuous moderate energy restriction in diet-
induced obese mice. Weight loss efficiency is defined here as the amount of weight lost per unit
of energy restriction (g/kJ). So, despite eating significantly more than their counterparts on the
continuous diet, mice on the intermittent diet achieved the same results in terms of reductions
in body weight. Mice on the intermittent diet also achieved similar results to mice on the con-
tinuous diet in terms of reductions in body fat, lean mass, and fasting serum glucose and insu-
lin levels, as well as a better outcome in terms of maintenance of seminal vesicle weight, an
indicator of activity of the hypothalamo-pituitary-gonadal axis [40,41].
The current findings are of potential clinical significance because nutritional deficiencies,
especially micronutrient deficiencies, are common amongst individuals with overweight and
obesity, an effect that can be exacerbated by dietary restriction [42]. As such, achieving equiva-
lent weight and fat loss on a higher energy intake could reduce the risk of nutritional deficien-
cies during weight loss interventions, provided that nutrient-rich foods are selected.
Additionally, while intermittent fasting diets involving severe energy restriction appear no eas-
ier to comply with than continuous moderate energy restriction, as indicated by a lack of clear
unidirectional difference in participant retention rates in clinical trials [17], a diet involving
moderate energy restriction, interrupted by periods of normal food intake, may be easier to
adhere to. Considering the 11.5% greater overall energy intake of mice on the intermittent ver-
sus those on the continuous diet, this difference would equate to an average of 820 kJ per day
more energy intake for humans on an intermittent versus a continuous diet, assuming a weight
maintenance energy requirement of 8,700 kJ per day and an energy intake of 7,130 kJ per day
on a continuous diet involving 18% energy restriction. 820 kJ is the amount of energy found in
a small meal or substantial snack, such as a medium-sized egg (48 g) on a thin slice of bread
(30 g) spread with a teaspoon of butter or margarine (5 g) and served with a small tomato (100
g). Given that hunger is a common side effect of continuous diets involving moderate energy
restriction [43–45], the possibility of losing the same amount of weight while consuming an
average of 820 kJ more per day would thus likely hold appeal to people embarking on a weight
loss program. This has potential implications for the long-term management of obesity, to be
discussed further below.
While there is theoretical rationale to expect that intermittent energy restriction might lead
to greater weight loss efficiency than continuous energy restriction, to our knowledge this is
the first intermittent diet protocol to show improved weight loss efficiency relative to continu-
ous energy restriction. Evidence that the ‘metabolic rest periods’ of ad libitum food intake
high fat diet; CD, continuous diet; ID, intermittent diet. Data are means ± SEM of 4 mice per group. * P<0.05,
** P<0.01 versus CAC. § P<0.05 versus CAF.
doi:10.1371/journal.pone.0145157.g005
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abated the reduced energy expenditure and other metabolic changes that inhibit fat loss and
increased drive to eat in our intermittent diet protocol can be seen not only from the improved
weight loss efficiency, but also from the fact that whereas mice on the intermittent diet were
markedly hyperphagic relative to non-dieting controls on the first day of ad libitum food
intake, by the second and third day, energy intake was not significantly greater than that of
these controls. Intermittent energy restriction has been examined in several previous publica-
tions, but relatively few studies have made head-to-head comparisons of the effects of continu-
ous versus intermittent energy restriction on weight or fat loss in rodents [4,8–10] or humans
[2,3,6,7,46–53]. While all but one [4] of these intermittent energy restriction protocols resulted
in significant fat and / or weight loss compared to baseline, only one of these studies [50]
showed evidence of improved weight loss or fat loss efficiency when compared to continuous
energy restriction, like in the current study, as indicated by similar fat and / or weight loss
despite greater reported energy intake with intermittent energy restriction. This may be at least
partially because all but three [3,9,50] previous comparisons of intermittent versus continuous
energy restriction used severe energy restriction in the intermittent but not in the continuous
arm [2,4,6–8,10,46–49,53], and more severe energy restriction has been shown to reduce
weight loss efficiency [21–23]. Of these three studies that used intermittent moderate energy
restriction in mice [9] or humans [3,50], there was insufficient data available to definitively
assess weight loss efficiency compared to continuous moderate energy restriction. It is notori-
ously difficult to control or even just assess energy intake in free-living humans [32]. Thus the
current study in mice—while essentially descriptive in nature—has provided insight into the
weight loss efficiency of intermittent versus continuous moderate energy restriction, insight
that would be difficult to attain in free-living humans. In summary, we believe that the use of
moderate energy restriction as part of intermittent dieting strategies is a promising angle of
investigation for future human obesity treatments.
We initially hypothesized that the mechanism by which intermittent moderate energy
restriction improved weight loss efficiency and maintenance of seminal vesicle weight could
involve attenuation of hypothalamic expression of the orexigenic peptides, NPY and AgRP.
Indeed, energy restriction in rodents increases the hypothalamic expression of NPY and AgRP,
which induce a heightened drive to eat as well as a reduction in energy expenditure and inhibi-
tion of the hypothalamo-pituitary-gonadal axis, as previously reviewed [24,25]. It is also
known that the effect of energy restriction to increase hypothalamic NPY or AgRP expression
is significantly reduced or completely abolished within one day of ad libitum access to food
[54–57]. Contrary to our hypothesis, however, we did not observe any effect of continuous
moderate energy restriction to increase hypothalamic expression of NPY or AgRP mRNA rela-
tive to controls with continuous ad libitum chow access, perhaps because moderate energy
restriction was used in our current experiments, unlike other publications that used severe
energy restriction (fasting) [54–58]. Also contrary to our hypothesis, we did not observe any
difference between mice on the continuous and intermittent diets with respect to hypothalamic
NPY or AgRP concentrations. What we did see, however, was a significantly greater hypotha-
lamic POMCmRNA expression in mice on the continuous diet versus controls with ad libitum
chow access, with no such significant increase seen in mice on the intermittent diet. While the
hypothalamic POMC gene produces the anorexigenic peptide, α-MSH, it also produces several
other products with opposing effects on food intake or energy metabolism, one of which is β-
endorphin [37]. β-endorphin increases energy intake and body weight [59], at least partially
via antagonism of the anorexigenic and weight-reducing effect of α-MSH [60]. β-endorphin is
also known to inhibit the hypothalamo-pituitary-gonadal axis in several species, via actions in
the hypothalamus and peripheral tissues [61,62], consistent with the significantly reduced sem-
inal vesicle weight seen in mice on the continuous but not the intermittent diet. These
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suppositions are speculative, however, and further work would be required to show whether or
not reduced hypothalamic POMC expression—as well as other pathways, such as reduced gut
nutrient absorption, increased thyroid function and increased energy expenditure—might be
related to the effects of intermittent versus continuous energy restriction.
Despite exhibiting improved weight loss efficiency, mice on the intermittent diet were not
protected from weight regain upon longer-term reinstatement of ad libitum access to normal
chow or the high fat diet, gaining just as much weight and fat mass as animals on the continu-
ous diet. Therefore, as is often the case in people with a body mass index in the obese range,
long-term maintenance of the reduced body weight would require ongoing energy restriction.
Given that energy restriction that is deliberately interrupted with periods of ad libitum food
intake would conceivably be easier to adhere to than continuous energy restriction, we believe
that this strategy may be more suitable for long-term maintenance of a reduced body weight
than continuous energy restriction. Further work is required to assess these possibilities in
humans.
Weight loss is known to improve glucose homeostasis and to reduce the risk of progression
to type 2 diabetes mellitus [1]. Most head to head comparisons have suggested that intermittent
severe energy restriction produces similar benefits to continuous moderate energy restriction
for reducing fasting circulating levels of glucose, insulin and glycated haemoglobin (HbA1c), as
recently reviewed [17]. Only three publications in humans have reported a greater decrease in
fasting circulating concentrations of glucose [3,7], insulin or HOMA-IR [6,7] with certain
forms of intermittent severe energy restriction versus continuous moderate energy restriction.
Similarly, one study in mice showed greater reductions in fasting or glucose- or insulin-
induced circulating glucose or insulin levels with intermittent compared to continuous energy
restriction [8]. In contrast, another study in rats showed no effect of intermittent severe energy
restriction to reduce plasma glucose concentrations, unlike the hypoglycemic effect of continu-
ous moderate energy restriction [10]. In the current study we did not find evidence of any
greater benefit of intermittent over continuous moderate energy restriction for reducing circu-
lating glucose or insulin concentrations, or HOMA-IR, in mice, albeit animals were not studied
in response to in vivo challenges such as glucose or insulin injection, or analysis of insulin sig-
naling in insulin target tissues, which could have revealed subtle differences not apparent in the
fasting glucose and insulin concentrations assessed here. Further, dedicated studies with a
larger number of mice would be required to fully address this.
Moderate energy restriction is frequently used for the management of overweight and obe-
sity in humans. The results from this study in mice raise the possibility that the efficiency of
moderate energy restriction for weight loss could be significantly improved if it were applied
intermittently, by allowing regular periods of ad libitum food intake. This finding has potential
benefits for ensuring nutritional adequacy and long-term compliance with the diet. Further
work is required to determine the optimum timing of such ‘metabolic rest periods’ when
applied in humans. Moreover, care would need to be taken to ensure that the overall diet
selected is nutrient-rich and not obesogenic, and that the level of intake is in accordance with
physical hunger signals or energy requirements, not factors such as habits or emotions that
could lead to excessive food intake and weight gain.
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